株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

肝炎診断検査の世界市場:業界動向、市場シェア、市場規模、成長性、市場機会、および将来予測

Hepatitis Diagnostic Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

発行 IMARC Services Private Limited 商品コード 788437
出版日 ページ情報 英文 90 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=113.28円で換算しております。
Back to Top
肝炎診断検査の世界市場:業界動向、市場シェア、市場規模、成長性、市場機会、および将来予測 Hepatitis Diagnostic Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
出版日: 2019年02月11日 ページ情報: 英文 90 Pages
概要

当レポートでは、肝炎診断検査の世界市場を取り上げ、業界動向や市場実績、価格動向、また市場競争状況など広範な調査に基づいて、SWOT分析、Porterのファイブフォース分析、バリューチェーン分析等の重要な市場分析結果を提供しています。さらに市場を検査タイプ別および地域別に分類し、詳細な分析と将来予測を行っています。

第1章 前書き

第2章 調査範囲および調査手法

  • 調査目的
  • 利害関係者
  • データソース
  • 市場見積法
  • 予測手法

第3章 エグゼクティブ・サマリー

第4章 序論

  • 市場概要
  • 主要業界動向

第5章 肝炎診断検査世界市場

  • 市場概要
  • 市場実績
  • 検査タイプ別市場分析
  • 地域別市場分析
  • 市場予測
  • SWOT分析
  • バリューチェーン分析
  • Porterのファイブフォース分析
  • 価格分析

第6章 検査タイプ別市場分析

  • 血液検査
    • 市場動向
    • 市場予測
  • 画像検査
    • 市場動向
    • 市場予測
  • 肝生検
    • 市場動向
    • 市場予測

第7章 地域別市場分析

  • 北米
    • 市場動向
    • 市場予測
  • アジア太平洋
    • 市場動向
    • 市場予測
  • 欧州
    • 市場動向
    • 市場予測
  • 中東およびアフリカ
    • 市場動向
    • 市場予測
  • ラテンアメリカ
    • 市場動向
    • 市場予測

第8章 市場競争状況

  • 市場構造
  • 主要企業
  • 主要企業プロファイル
    • Siemens AG
    • Abbott Laboratories
    • MedMira Inc
    • Qaigen Inc
    • Beckman Coulter Inc (Danaher Corporation)
    • F. Hoffmann Roche
    • Diasorin S.p.A
    • bioMeriuex
    • Hologic Inc
    • Bio-Rad Laboratories Inc
図表

List of Figures

  • Figure 1: Global: Hepatitis Diagnostic Tests Market: Major Drivers and Challenges
  • Figure 2: Global: Hepatitis Diagnostic Tests Market: Sales Value (in Billion US$), 2013-2018
  • Figure 3: Global: Hepatitis Diagnostic Tests Market: Breakup by Test Type (in %), 2018
  • Figure 4: Global: Hepatitis Diagnostic Tests Market: Breakup by Region (in %), 2018
  • Figure 5: Global: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 6: Global: Hepatitis Diagnostic Tests Industry: SWOT Analysis
  • Figure 7: Global: Hepatitis Diagnostic Tests Industry: Value Chain Analysis
  • Figure 8: Global: Hepatitis Diagnostic Tests Industry: Porter's Five Forces Analysis
  • Figure 9: Global: Hepatitis Diagnostic Tests (Blood Test) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 10: Global: Hepatitis Diagnostic Tests (Blood Tests) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 11: Global: Hepatitis Diagnostic Tests (Imaging Test) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 12: Global: Hepatitis Diagnostic Tests (Imaging Test) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 13: Global: Hepatitis Diagnostic Tests (Liver Biopsy) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 14: Global: Hepatitis Diagnostic Tests (Liver Biopsy) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 15: North America: Hepatitis Diagnostic Tests Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 16: North America: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 17: Asia Pacific: Hepatitis Diagnostic Tests Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 18: Asia Pacific: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 19: Europe: Hepatitis Diagnostic Tests Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 20: Europe: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 21: Middle East and Africa: Hepatitis Diagnostic Tests Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 22: Middle East and Africa: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 23: Latin America: Hepatitis Diagnostic Tests Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 24: Latin America: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

  • Table 1: Global: Hepatitis Diagnostic Tests Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Global: Hepatitis Diagnostic Tests Market Forecast: Breakup by Test Type (in Million US$), 2019-2024
  • Table 3: Global: Hepatitis Diagnostic Tests Market Forecast: Breakup by Region (in Million US$), 2019-2024
  • Table 4: Global: Hepatitis Diagnostic Tests Market: Competitive Structure
  • Table 5: Global: Hepatitis Diagnostic Tests Market: Key Players
目次
Product Code: SR1018H16_Report

The global hepatitis diagnostic tests market was worth US$ 3.8 Billion in 2018. Hepatitis represents a major global health threat that requires an urgent response. According to estimates, hepatitis causes 1.3 Million-1.5 Million deaths each year, a figure that is comparable to the deaths caused by tuberculosis and even higher than those caused by HIV. Moreover, while mortality from diseases such as HIV, tuberculosis, and malaria are now declining, mortality from hepatitis has been rising. According to estimates around 325-350 Million people across the globe are carriers of hepatitis B or C virus infections, which may remain asymptomatic for decades. Moreover, every year, around 1.75 Million people get infected by the hepatitis C virus infection. Unless these people receive timely testing and treatment, they are at risk of severe liver disease and even death. Diagnostic tests help in the early detection of hepatitis infections and increase the chances of survival of the patient by correct medication and treatment.

The global demand of hepatitis diagnostic tests is currently exhibiting strong growth. This market is currently being catalyzed by a number of factors such as the increasing burden of hepatitis across the globe, rising number of blood transfusions and donations, technological advancements and the advantages offered by PoC (Point of Care) test, and rising awareness levels. A major trend being witnessed in this market has been a shift from conventional testing methods to molecular diagnostics. This has resulted in an increased accuracy and reduced the total time required to get the results. Looking forward, the market value is projected to reach US$ 5.4 Billion by 2024, exhibiting a CAGR of 6% during 2019-2024.

Market Summary:

Based on the test type, the market has been segmented into blood tests, imaging test and liver biopsy. Blood tests currently represent the biggest application. Blood tests are further segmented into liver function test, immunoassays, and nucleic acid tests. Liver function tests currently represent the biggest segment.

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global market.

The competitive landscape of the market has also been examined with some of the key players being Siemens AG, Abbott Laboratories, MedMira Inc, Qaigen Inc, Beckman Coulter Inc (Danaher Corporation), F. Hoffmann Roche, Diasorin S.p.A, bioMeriuex, Hologic Inc and Bio-Rad Laboratories Inc.

Key Questions Answered in This Report:

  • How has the global hepatitis diagnostic tests market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global hepatitis diagnostic tests industry?
  • What is the breakup of the global hepatitis diagnostic tests market on the basis of test type?
  • What are the various stages in the value chain of the global hepatitis diagnostic tests market?
  • What are the key driving factors and challenges in the global hepatitis diagnostic tests market?
  • What is the structure of the global hepatitis diagnostic tests market and who are the key players?
  • What is the degree of competition in the global hepatitis diagnostic tests market?

Table of Contents

1. Preface

2. Scope and Methodology

  • 2.1. Objectives of the Study
  • 2.2. Stakeholders
  • 2.3. Data Sources
    • 2.3.1. Primary Sources
    • 2.3.2. Secondary Sources
  • 2.4. Market Estimation
    • 2.4.1. Bottom-Up Approach
    • 2.4.2. Top-Down Approach
  • 2.5. Forecasting Methodology

3. Executive Summary

4. Introduction

  • 4.1. Overview
  • 4.2. Key Industry Trends

5. Global Hepatitis Diagnostic Tests Market

  • 5.1. Market Overview
  • 5.2. Market Performance
  • 5.3. Market Breakup by Test Type
  • 5.4. Market Breakup by Region
  • 5.5. Market Forecast
  • 5.6. SWOT Analysis
    • 5.6.1. Overview
    • 5.6.2. Strengths
    • 5.6.3. Weaknesses
    • 5.6.4. Opportunities
    • 5.6.5. Threats
  • 5.7. Value Chain Analysis
  • 5.8. Porters Five Forces Analysis
    • 5.8.1. Overview
    • 5.8.2. Bargaining Power of Buyers
    • 5.8.3. Bargaining Power of Suppliers
    • 5.8.4. Degree of Competition
    • 5.8.5. Threat of New Entrants
    • 5.8.6. Threat of Substitutes
  • 5.9. Price Analysis

6. Market Breakup by Test Type

  • 6.1. Blood Tests
    • 6.1.1. Market Trends
    • 6.1.2. Market Forecast
  • 6.2. Imaging Test
    • 6.2.1. Market Trends
    • 6.2.2. Market Forecast
  • 6.3. Liver Biopsy
    • 6.3.1. Market Trends
    • 6.3.2. Market Forecast

7. Market Breakup by Region

  • 7.1. North America
    • 7.1.1. Market Trends
    • 7.1.2. Market Forecast
  • 7.2. Asia Pacific
    • 7.2.1. Market Trends
    • 7.2.2. Market Forecast
  • 7.3. Europe
    • 7.3.1. Market Trends
    • 7.3.2. Market Forecast
  • 7.4. Middle East and Africa
    • 7.4.1. Market Trends
    • 7.4.2. Market Forecast
  • 7.5. Latin America
    • 7.5.1. Market Trends
    • 7.5.2. Market Forecast

8. Competitive Landscape

  • 8.1. Market Structure
  • 8.2. Key Players
  • 8.3. Profiles of Key Players
    • 8.3.1. Siemens AG
    • 8.3.2. Abbott Laboratories
    • 8.3.3. MedMira Inc
    • 8.3.4. Qaigen Inc
    • 8.3.5. Beckman Coulter Inc (Danaher Corporation)
    • 8.3.6. F. Hoffmann Roche
    • 8.3.7. Diasorin S.p.A
    • 8.3.8. bioMeriuex
    • 8.3.9. Hologic Inc
    • 8.3.10 Bio-Rad Laboratories Inc
Back to Top